Annual FCF
$110.53 M
-$5.88 M-5.05%
December 31, 2023
Summary
- As of February 12, 2025, SUPN annual free cash flow is $110.53 million, with the most recent change of -$5.88 million (-5.05%) on December 31, 2023.
- During the last 3 years, SUPN annual FCF has fallen by -$24.18 million (-17.95%).
- SUPN annual FCF is now -22.02% below its all-time high of $141.74 million, reached on December 31, 2019.
Performance
SUPN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$53.32 M
+$17.76 M+49.94%
September 30, 2024
Summary
- As of February 12, 2025, SUPN quarterly free cash flow is $53.32 million, with the most recent change of +$17.76 million (+49.94%) on September 30, 2024.
- Over the past year, SUPN quarterly FCF has increased by +$17.59 million (+49.25%).
- SUPN quarterly FCF is now -41.67% below its all-time high of $91.42 million, reached on June 30, 2020.
Performance
SUPN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$172.03 M
+$17.59 M+11.39%
September 30, 2024
Summary
- As of February 12, 2025, SUPN TTM free cash flow is $172.03 million, with the most recent change of +$17.59 million (+11.39%) on September 30, 2024.
- Over the past year, SUPN TTM FCF has increased by +$78.91 million (+84.75%).
- SUPN TTM FCF is now -3.41% below its all-time high of $178.10 million, reached on June 30, 2020.
Performance
SUPN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SUPN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.0% | +49.3% | +84.8% |
| 3 y3 years | -17.9% | +49.3% | +84.8% |
| 5 y5 years | -13.7% | +49.3% | +84.8% |
SUPN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.6% | at low | -25.6% | +380.1% | at high | +142.0% |
| 5 y | 5-year | -22.0% | at low | -41.7% | +380.1% | -3.4% | +142.0% |
| alltime | all time | -22.0% | +285.5% | -41.7% | +375.3% | -3.4% | +358.4% |
Supernus Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $53.32 M(+49.9%) | $172.03 M(+11.4%) |
| Jun 2024 | - | $35.56 M(-6.8%) | $154.43 M(+54.7%) |
| Mar 2024 | - | $38.15 M(-15.2%) | $99.84 M(-9.7%) |
| Dec 2023 | $110.53 M(-5.1%) | $44.99 M(+25.9%) | $110.53 M(+18.7%) |
| Sep 2023 | - | $35.73 M(-287.7%) | $93.11 M(+31.0%) |
| Jun 2023 | - | -$19.03 M(-139.0%) | $71.08 M(-56.1%) |
| Mar 2023 | - | $48.85 M(+77.2%) | $161.81 M(+39.0%) |
| Dec 2022 | $116.41 M(-6.9%) | $27.57 M(+101.4%) | $116.41 M(-15.4%) |
| Sep 2022 | - | $13.69 M(-80.9%) | $137.56 M(+14.9%) |
| Jun 2022 | - | $71.69 M(+1977.5%) | $119.72 M(+27.0%) |
| Mar 2022 | - | $3.45 M(-92.9%) | $94.29 M(-24.6%) |
| Dec 2021 | $125.08 M(-7.1%) | $48.72 M(-1272.9%) | $125.08 M(+15.8%) |
| Sep 2021 | - | -$4.15 M(-109.0%) | $107.98 M(-8.0%) |
| Jun 2021 | - | $46.27 M(+35.1%) | $117.43 M(-27.8%) |
| Mar 2021 | - | $34.24 M(+8.3%) | $162.57 M(+20.7%) |
| Dec 2020 | $134.71 M(-5.0%) | $31.62 M(+497.0%) | $134.71 M(-7.9%) |
| Sep 2020 | - | $5.30 M(-94.2%) | $146.20 M(-17.9%) |
| Jun 2020 | - | $91.42 M(+1333.1%) | $178.10 M(+54.4%) |
| Mar 2020 | - | $6.38 M(-85.2%) | $115.35 M(-18.6%) |
| Dec 2019 | $141.74 M(+10.6%) | $43.11 M(+15.9%) | $141.74 M(+7.9%) |
| Sep 2019 | - | $37.20 M(+29.8%) | $131.38 M(-16.0%) |
| Jun 2019 | - | $28.66 M(-12.5%) | $156.44 M(+16.7%) |
| Mar 2019 | - | $32.77 M(+0.1%) | $134.03 M(+4.6%) |
| Dec 2018 | $128.14 M(+13.8%) | $32.75 M(-47.4%) | $128.14 M(-2.2%) |
| Sep 2018 | - | $62.26 M(+895.8%) | $130.97 M(+22.1%) |
| Jun 2018 | - | $6.25 M(-76.7%) | $107.30 M(-15.1%) |
| Mar 2018 | - | $26.88 M(-24.4%) | $126.43 M(+12.3%) |
| Dec 2017 | $112.61 M | $35.58 M(-7.8%) | $112.61 M(+10.8%) |
| Sep 2017 | - | $38.58 M(+52.0%) | $101.67 M(+11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $25.39 M(+94.4%) | $90.92 M(+11.3%) |
| Mar 2017 | - | $13.06 M(-47.0%) | $81.69 M(+25.3%) |
| Dec 2016 | $65.21 M(+101.1%) | $24.64 M(-11.5%) | $65.21 M(+9.3%) |
| Sep 2016 | - | $27.84 M(+72.4%) | $59.63 M(+79.5%) |
| Jun 2016 | - | $16.15 M(-572.2%) | $33.22 M(+12.8%) |
| Mar 2016 | - | -$3.42 M(-117.9%) | $29.45 M(-9.2%) |
| Dec 2015 | $32.42 M(-229.2%) | $19.06 M(+1240.6%) | $32.42 M(+66.2%) |
| Sep 2015 | - | $1.42 M(-88.5%) | $19.50 M(+46.9%) |
| Jun 2015 | - | $12.39 M(-2828.9%) | $13.27 M(-314.9%) |
| Mar 2015 | - | -$454.00 K(-107.4%) | -$6.17 M(-75.4%) |
| Dec 2014 | -$25.09 M(-57.9%) | $6.14 M(-227.8%) | -$25.09 M(-38.2%) |
| Sep 2014 | - | -$4.81 M(-31.9%) | -$40.58 M(-22.0%) |
| Jun 2014 | - | -$7.06 M(-63.6%) | -$52.01 M(-15.3%) |
| Mar 2014 | - | -$19.37 M(+107.2%) | -$61.37 M(+3.0%) |
| Dec 2013 | -$59.59 M(+24.3%) | -$9.35 M(-42.4%) | -$59.59 M(-10.5%) |
| Sep 2013 | - | -$16.23 M(-1.1%) | -$66.59 M(+7.3%) |
| Jun 2013 | - | -$16.42 M(-6.7%) | -$62.05 M(+11.9%) |
| Mar 2013 | - | -$17.59 M(+7.7%) | -$55.44 M(+15.6%) |
| Dec 2012 | -$47.95 M(+30.1%) | -$16.34 M(+39.7%) | -$47.95 M(+19.7%) |
| Sep 2012 | - | -$11.70 M(+19.2%) | -$40.06 M(+6.7%) |
| Jun 2012 | - | -$9.81 M(-3.0%) | -$37.55 M(+1.5%) |
| Mar 2012 | - | -$10.11 M(+19.6%) | -$36.97 M(+0.3%) |
| Dec 2011 | -$36.87 M(+12.3%) | -$8.45 M(-8.0%) | -$36.87 M(+29.7%) |
| Sep 2011 | - | -$9.18 M(-0.6%) | -$28.42 M(+47.7%) |
| Jun 2011 | - | -$9.24 M(-7.7%) | -$19.24 M(+92.3%) |
| Mar 2011 | - | -$10.00 M | -$10.00 M |
| Dec 2010 | -$32.84 M(-1810.3%) | - | - |
| Dec 2009 | $1.92 M(-106.4%) | - | - |
| Dec 2008 | -$29.79 M(+98.0%) | - | - |
| Dec 2007 | -$15.04 M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual FCF year-on-year change?
- What is Supernus Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly FCF year-on-year change?
- What is Supernus Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM FCF year-on-year change?
What is Supernus Pharmaceuticals annual free cash flow?
The current annual FCF of SUPN is $110.53 M
What is the all time high annual FCF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual free cash flow is $141.74 M
What is Supernus Pharmaceuticals annual FCF year-on-year change?
Over the past year, SUPN annual free cash flow has changed by -$5.88 M (-5.05%)
What is Supernus Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of SUPN is $53.32 M
What is the all time high quarterly FCF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly free cash flow is $91.42 M
What is Supernus Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, SUPN quarterly free cash flow has changed by +$17.59 M (+49.25%)
What is Supernus Pharmaceuticals TTM free cash flow?
The current TTM FCF of SUPN is $172.03 M
What is the all time high TTM FCF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM free cash flow is $178.10 M
What is Supernus Pharmaceuticals TTM FCF year-on-year change?
Over the past year, SUPN TTM free cash flow has changed by +$78.91 M (+84.75%)